The global paper diagnostics market is projected to reach USD 18.51 billion in 2025 and grow to USD 31.80 billion by 2034, expanding at a CAGR of 6.20%. Driven by the need for affordable, rapid, and decentralized diagnostic solutions, the market is gaining traction across clinical, emergency, and remote healthcare settings.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Paper Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Paper Diagnostics Market Revenue and Volume Forecast, by Kit Type
8.1.1. Lateral Flow Assays
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Paper Based Microfluidics
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Dipsticks
8.1.3.1. Market Revenue and Volume Forecast
9.1. Paper Diagnostics Market Revenue and Volume Forecast, by Device Type
9.1.1. Diagnostic Devices
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Monitoring Devices
9.1.2.1. Market Revenue and Volume Forecast
10.1. Paper Diagnostics Market Revenue and Volume Forecast, by End-use
10.1.1. Assisted Living Healthcare Facilities
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Hospital and Clinics
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Home Healthcare
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Others
10.1.4.1. Market Revenue and Volume Forecast
11.1. Paper Diagnostics Market Revenue and Volume Forecast, by Application
11.1.1. Food Quality Testing
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Environmental Monitoring
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Clinical Diagnostics
11.1.3.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Kit Type
12.1.2. Market Revenue and Volume Forecast, by Device Type
12.1.3. Market Revenue and Volume Forecast, by End-use
12.1.4. Market Revenue and Volume Forecast, by Application
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Kit Type
12.1.5.2. Market Revenue and Volume Forecast, by Device Type
12.1.5.3. Market Revenue and Volume Forecast, by End-use
12.1.5.4. Market Revenue and Volume Forecast, by Application
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Kit Type
12.1.6.2. Market Revenue and Volume Forecast, by Device Type
12.1.6.3. Market Revenue and Volume Forecast, by End-use
12.1.6.4. Market Revenue and Volume Forecast, by Application
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Kit Type
12.2.2. Market Revenue and Volume Forecast, by Device Type
12.2.3. Market Revenue and Volume Forecast, by End-use
12.2.4. Market Revenue and Volume Forecast, by Application
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Kit Type
12.2.5.2. Market Revenue and Volume Forecast, by Device Type
12.2.5.3. Market Revenue and Volume Forecast, by End-use
12.2.5.4. Market Revenue and Volume Forecast, by Application
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Kit Type
12.2.6.2. Market Revenue and Volume Forecast, by Device Type
12.2.6.3. Market Revenue and Volume Forecast, by End-use
12.2.6.4. Market Revenue and Volume Forecast, by Application
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Kit Type
12.2.7.2. Market Revenue and Volume Forecast, by Device Type
12.2.7.3. Market Revenue and Volume Forecast, by End-use
12.2.7.4. Market Revenue and Volume Forecast, by Application
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Kit Type
12.2.8.2. Market Revenue and Volume Forecast, by Device Type
12.2.8.3. Market Revenue and Volume Forecast, by End-use
12.2.8.4. Market Revenue and Volume Forecast, by Application
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Kit Type
12.3.2. Market Revenue and Volume Forecast, by Device Type
12.3.3. Market Revenue and Volume Forecast, by End-use
12.3.4. Market Revenue and Volume Forecast, by Application
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Kit Type
12.3.5.2. Market Revenue and Volume Forecast, by Device Type
12.3.5.3. Market Revenue and Volume Forecast, by End-use
12.3.5.4. Market Revenue and Volume Forecast, by Application
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Kit Type
12.3.6.2. Market Revenue and Volume Forecast, by Device Type
12.3.6.3. Market Revenue and Volume Forecast, by End-use
12.3.6.4. Market Revenue and Volume Forecast, by Application
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Kit Type
12.3.7.2. Market Revenue and Volume Forecast, by Device Type
12.3.7.3. Market Revenue and Volume Forecast, by End-use
12.3.7.4. Market Revenue and Volume Forecast, by Application
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Kit Type
12.3.8.2. Market Revenue and Volume Forecast, by Device Type
12.3.8.3. Market Revenue and Volume Forecast, by End-use
12.3.8.4. Market Revenue and Volume Forecast, by Application
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Kit Type
12.4.2. Market Revenue and Volume Forecast, by Device Type
12.4.3. Market Revenue and Volume Forecast, by End-use
12.4.4. Market Revenue and Volume Forecast, by Application
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Kit Type
12.4.5.2. Market Revenue and Volume Forecast, by Device Type
12.4.5.3. Market Revenue and Volume Forecast, by End-use
12.4.5.4. Market Revenue and Volume Forecast, by Application
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Kit Type
12.4.6.2. Market Revenue and Volume Forecast, by Device Type
12.4.6.3. Market Revenue and Volume Forecast, by End-use
12.4.6.4. Market Revenue and Volume Forecast, by Application
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Kit Type
12.4.7.2. Market Revenue and Volume Forecast, by Device Type
12.4.7.3. Market Revenue and Volume Forecast, by End-use
12.4.7.4. Market Revenue and Volume Forecast, by Application
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Kit Type
12.4.8.2. Market Revenue and Volume Forecast, by Device Type
12.4.8.3. Market Revenue and Volume Forecast, by End-use
12.4.8.4. Market Revenue and Volume Forecast, by Application
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Kit Type
12.5.2. Market Revenue and Volume Forecast, by Device Type
12.5.3. Market Revenue and Volume Forecast, by End-use
12.5.4. Market Revenue and Volume Forecast, by Application
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Kit Type
12.5.5.2. Market Revenue and Volume Forecast, by Device Type
12.5.5.3. Market Revenue and Volume Forecast, by End-use
12.5.5.4. Market Revenue and Volume Forecast, by Application
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Kit Type
12.5.6.2. Market Revenue and Volume Forecast, by Device Type
12.5.6.3. Market Revenue and Volume Forecast, by End-use
12.5.6.4. Market Revenue and Volume Forecast, by Application
13.1. Abbott (Alere Inc.)
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Bio-Rad Laboratories, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Diagnostics for All, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Arkray, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Acon Laboratories, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Ffei Life Science (Biognostix)
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Kenosha Tapes
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Gvs S.P.A.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Micro Essential Laboratory Inc
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Navigene
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description